awmsg logo



coagulation factor VIII/von Willebrand factor (Voncento®)


Reference No. 2226

Publication date:
13/12/2013


Appraisal information

coagulation factor VIII/von Willebrand factor (Voncento®) 250 IU/600 IU powder and solvent for solution for injection/infusion
coagulation factor VIII/von Willebrand factor (Voncento®) 500 IU/1200 IU powder and solvent for solution for injection/infusion
coagulation factor VIII/von Willebrand factor (Voncento®) 1000 IU/2400 IU powder and solvent for solution for injection/infusion


Company: CSL Behring UK Ltd
BNF category: Cardiovascular system
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 06/12/2013

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, coagulation factor VIII/Von Willebrand factor (Voncento®) cannot be endorsed for use within NHS Wales for the treatment of haemorrhage or prevention and treatment of surgical bleeding in patients with Von Willebrand disease, when desmopressin treatment alone is ineffective or contraindicated and prophylaxis and treatment of bleeding in patients with haemophilia A (congenital factor VIII deficiency).